[Gujarat India, 2025-09-08] — Premier Medical Corporation is proud to announce the launch of the First Response® Malaria Ag. P. falciparum (HRP2/pLDH) Card Test, a rapid, single-line diagnostic solution designed to enhance malaria detection in both laboratory and point-of-care environments.

Developed for use by trained healthcare professionals, this innovative test enables qualitative screening for Histidine Rich Protein 2 (HRP2) and/or Plasmodium lactate dehydrogenase (pLDH) antigens associated with Plasmodium falciparum infections. The unique single-line dual-antigen detection system simplifies interpretation while maintaining exceptional diagnostic accuracy.

The test delivers 100% sensitivity and 100% specificity, providing reliable results critical for timely medical decisions. With a rapid turnaround time of 20–30 minutes, it supports prompt identification and intervention in malaria-endemic regions.

Key Product Features

• Single-line detection of HRP2 and/or pLDH antigens

• 100% Sensitivity and 100% Specificity

• Rapid results: 20–30 minutes

• Suitable for laboratory and point-of-care testing environments

• Whole blood specimen

• Stable storage at 1°C – 40°C

• Simple, user-friendly card-based format

Premier Medical Corporation continues to advance high-quality diagnostic technologies that strengthen early detection and improve health outcomes globally.

For more information about the First Response® Malaria Ag. P. falciparum (HRP2/pLDH) Card Test, please contact our customer support team or visit our product pages.